Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas

We conducted a prospective phase II trial of pentostatin, cyclophosphamide and rituximab as initial therapy for patients with previously untreated advanced stage low-grade or indolent B-cell lymphomas (iNHLs). Of 83 evaluable patients, 91·6% attained an overall response and 86·8% a complete or uncon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Samaniego, Felipe, Hagemeister, Fredrick, Romaguera, Jorge E., Fanale, Michelle A., Pro, Barbara, McLaughlin, Peter, Rodriguez, M. Alma, Neelapu, Sattva S., Fayad, Luis, Younes, Anas, Feng, Lei, Berkova, Zuzana, Khashab, Tamer, Sehgal, Lalit, Vega-Vasquez, Francisco, Kwak, Larry W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278955/
https://ncbi.nlm.nih.gov/pubmed/25828695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13367
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados